New York Times reporter Pam Belluck writes that MIT researchers have found exposure to a specific combination of light and sound could improve Alzheimer’s symptoms. “It’s stunning that the intervention had beneficial effects on so many different aspects of Alzheimer-like pathology,” said Dr. Lennart Mucke, director of the Gladstone Institute of Neurological Disease.
Fast Company reporter Mark Wilson writes that CSAIL researchers have developed a new soft robotic gripper that is modeled after a Venus flytrap. “Dubbed the Magic Ball, it’s a rubber and plastic structure that can contract around an object like an origami flower,” Wilson explains.
Dr. Francis Collins, director of the NIH, details how MIT researchers have developed a new low-energy imaging approach called three-photon microscopy that allows exploration of all six layers of the visual cortex in a mammal’s brain. Collins notes that the researchers are proving themselves to be “biological explorers of the first order.”
CSAIL researchers have developed a new robotic gripper that contains an origami skeleton, enabling the device to open and close like a flower and grasp a variety of delicate and heavy objects, reports James Vincent for The Verge “By combining this foldable skeleton with the soft exterior, we get the best of both worlds,” explains Prof. Daniela Rus, director of CSAIL.
NBC News reporter Linda Caroll writes about a new study by MIT researchers showing that inactive ingredients in medications could lead to adverse reactions in some patients. The researchers found that some of the inactive ingredients “can worsen symptoms in people with conditions such as irritable bowel syndrome, or IBS.”
MIT researchers have developed a new drug-releasing coil that could be used to help treat tuberculosis, reports Ruby Prosser Scully for New Scientist. Scully explains that the coil is “too large to leave the stomach, so it stays there, and the medicines threaded onto it leach out at a rate depending on the type of drug and the polymer the developers use to make the pills.”
TIME reporter Alice Park writes that in a Nature commentary, an international group of scientists has called for a temporary ban on studies using gene-editing on human embryos. “Our question is, how should nations make decisions about technologies like gene editing going forward?” says Prof. Eric Lander, director of the Broad Institute and one of the authors of the commentary.
Associated Press reporter Malcom Ritter writes that an international team of scientists – including a number of MIT researchers – has called for a moratorium on making babies with genetically engineered DNA. “The moratorium would allow time for discussion of technical, scientific, societal and ethical issues that must be considered,” explains Ritter.
Financial Times reporter Hannah Kuchler writes that researchers from MIT and a number of other institutions have called for a moratorium on editing inheritable human genes. Kuchler writes that the researchers called for the establishment of “an international framework on the conditions in which such editing could be allowed.”
TechCrunch reporter Brian Heater writes that researchers at CSAIL and Harvard have developed a soft robotic gripper that can both handle delicate objects and lift items up to 100 times its own weight. “The gripper itself is made of an origami-inspired skeletal structure, covered in either fabric or a deflated balloon,” explains Heater.
Gizmodo reporter Ed Cara writes about a study by MIT researchers have finds “inactive” ingredients in pills could trigger a patient’s allergies or intolerances. “We’re not saying that everyone should stop taking these medications,” explains Prof. Giovanni Traverso. “But people with an allergy or intolerance should definitely have the opportunity to find out if they have to worry about certain medications.”
MIT researchers have found that companies with experienced technologists on their boards tend to have better financial outcomes, reports Sara Castellanos and Angus Loten for The Wall Street Journal. “Directors on digitally savvy boards have an understanding, tested by experience, of how digital technologies impact the way that companies will succeed in the next decade,” explains research scientist Stephanie Woerner.
MIT researchers have found that many pills contain “inactive” ingredients that could be troublesome for patients, reports Richard Harris for NPR. Prof. Giovanni Traverso explains that if a patient with lactose intolerance takes a pill containing lactose, “it's probably not going to manifest in any significant symptoms. But as the number of pills you're taking [increases], then certainly you might cross that threshold."
AP reporter Lauran Neergaard writes that a new study by MIT researchers finds that pills often contain “inactive” ingredients capable of causing allergic or gastrointestinal reactions. The researchers found that “it’s hard for those patients, or even their doctors, to tell if a pill contains an extra ingredient they should avoid,” Neergaard explains.
In an article for Fast Company, Clifton Mark highlights a study by Prof. Emilio Castilla examining the impact of meritocratic practices. Castilla and his colleagues found that “in companies that explicitly held meritocracy as a core value, managers assigned greater rewards to male employees over female employees with identical performance evaluations.”